Clinical Trial

Risk Factors of Atrial Fibrillation After Cardiac Surgery

Study acronym: PFAS
Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated June 25, 2026 (before its estimated July 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
Supraventricular arrhythmias complicate more than 40% of cardiac surgeries and are associated with an increased risk of bleeding, stroke, heart failure, and death. Preventing the occurrence of these arrhythmias is a major challenge. This study aims to investigate risk factors and protective factors regarding atrial fibrillation and other iatrogenic cardiac arrhythmias after cardiac surgery, particularly innovative anesthetic strategies such as stellar ganglion blockade which have been recently implemented in our center.
Protocol Amendment History 2 changes
notable Primary completion pushed: 2026-06-01 -> 2026-07-01 2026-06-26
minor Completion pushed: 2026-06-01 -> 2026-07-01 2026-06-26
Trial Details
NCT Number NCT07625033
Lead Sponsor Centre Hospitalier Régional Metz-Thionville
Conditions Cardiac Surgery, Peri Operative Medicine, Thoracic Surgery, Cardiopulmonary Bypass, Coronary Artery Bypass, Heart Valve Prosthesis Implantation, Aortic Valve Replacement, Perioperative Medicine +7 more
Enrollment 918 participants
Start Date 2026-07-01
Primary Completion 2026-07-01 (estimated)
Study Completion 2026-07-01 (estimated)
Updated on ClinicalTrials.gov 2026-06-25